Warren Buffett Teva Pharmaceutical Industries LTD Transaction History

Berkshire Hathaway Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$7.9 - $10.19 $338 Million - $436 Million	-42,789,295 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$6.69 - $13.45 $3.08 Million - $6.19 Million	-460,000 Reduced 1.06%	42,789,295 $384 Million
Q2 2018 Aug 14, 2018	BUY	$16.77 - $24.71 $45.4 Million - $67 Million	2,709,585 Added 6.68%	43,249,295 $1.05 Billion
Q1 2018 May 15, 2018	BUY	$16.68 - $22.07 $361 Million - $478 Million	21,663,989 Added 114.77%	40,539,710 $693 Million
Q4 2017 Feb 14, 2018	BUY	$11.23 - $19.1 $212 Million - $361 Million	18,875,721	18,875,721 $358 Million

603

567M

25.2M

5.08M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.8B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Berkshire Hathaway Inc, based on Form 13F filings with the SEC.

Stay updated on Berkshire Hathaway Inc and Warren Buffett with notifications on news.